• Vaxcyte President and CFO Andrew Guggenhime exercised stock options for 10,000 common shares at USD 5.35 on June 18, 2026.
• He sold 10,000 common shares at USD 53 on the same day.
• Directly held common shares ended at 104,395 following the transactions.
• He also reported 61,850 common shares held indirectly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001230724-26-000010), on June 18, 2026, and is solely responsible for the information contained therein.